Key stats
About ARK GENOMIC
Expense ratio
0.79%
Home page
Inception date
Apr 12, 2024
ISIN
IE000O5M6XO1
The investment objective of the Fund is to generate long term capital growth (5 years or more)
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Technology Services
Stocks100.01%
Health Technology78.29%
Technology Services13.99%
Health Services7.72%
Bonds, Cash & Other−0.01%
Cash−0.01%
Stock breakdown by region
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history